Zai Lab (ZLAB) Current Deferred Revenue (2017 - 2022)
Zai Lab (ZLAB) posted Current Deferred Revenue of $26.9 million for Q1 2022, down 2.15% sequentially from $27.5 million in Q4 2021, and up 61.47% YoY from $16.7 million in Q1 2021.
Zai Lab (ZLAB) Current Deferred Revenue (2017 - 2022) Analysis & Trends
Zai Lab has reported Current Deferred Revenue for 6 years, with the latest figure at $26.9 million in Q1 2022.
- Quarterly Current Deferred Revenue rose 61.47% year-over-year to $26.9 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $26.9 million (up 61.47% YoY) and the FY2021 annual result came in at $27.5 million, up 63.04% from the prior year.
- Current Deferred Revenue fell to $26.9 million in Q1 2022 per ZLAB's latest filing, from $27.5 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $27.5 million in Q4 2021 and troughed at $2.1 million in Q4 2018.
- A 5-year average of $14.6 million and a median of $16.8 million in 2020 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2018 and 2020: Current Deferred Revenue retreated 13.79% in 2018, then surged 485.14% in 2020.
- Over 5 years, Current Deferred Revenue stood at $2.1 million in 2018, then soared by 39.58% to $2.9 million in 2019, then soared by 485.14% to $16.9 million in 2020, then jumped by 63.04% to $27.5 million in 2021, then declined by 2.15% to $26.9 million in 2022.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $26.9 million, $27.5 million, and $17.5 million for Q1 2022, Q4 2021, and Q3 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 26.90 Mn |
| Dec 31, 2021 | 27.49 Mn |
| Sep 30, 2021 | 17.49 Mn |
| Jun 30, 2021 | 17.63 Mn |
| Mar 31, 2021 | 16.66 Mn |
| Dec 31, 2020 | 16.86 Mn |
| Jun 30, 2020 | 15.74 Mn |
| Dec 31, 2019 | 2.88 Mn |
| Sep 30, 2019 | 2.76 Mn |
| Dec 31, 2018 | 2.06 Mn |
| Dec 31, 2017 | 2.39 Mn |